<DOC>
	<DOCNO>NCT00899652</DOCNO>
	<brief_summary>RATIONALE : Studying sample bone marrow blood patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This laboratory study look DNA bone marrow blood sample young patient acute myeloid leukemia acute lymphoblastic leukemia .</brief_summary>
	<brief_title>DNA Analysis Bone Marrow Blood Samples From Young Patients With Acute Myeloid Leukemia Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - Characterize clinical , morphologic , immunologic , cytogenetic , molecular heterogeneity acute lymphoblastic leukemia acute myeloid leukemia ( AML ) infants monoblastic variant AML young patient . - Characterize clinical , morphologic , immunologic , cytogenetic , molecular heterogeneity secondary AML young patient . - Compare secondary AML v de novo AML level Southern blot , breakpoint sequence , DNA topoisomerase II cleavage site . OUTLINE : This multicenter study . Bone marrow blood collect analyzed Southern blot chromosome 11q23 breakpoints translocation . Samples patient secondary acute myeloid leukemia also examine MLL gene rearrangement . PROJECTED ACCRUAL : A total 250 patient accrue study .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis leukemia meet 1 follow criterion : Acute lymphoblastic leukemia OR acute myeloid leukemia ( AML ) ( &lt; 1 year age diagnosis ) M4 OR M5 AML ( &lt; 5 year age diagnosis ) Secondary leukemia ( &lt; 21 year age diagnosis ) Bone marrow sample , peripheral blood ( WBC &gt; 10,000/mmÂ³ 20 % peripheral blast ) , pheresis bag available PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>childhood acute myelomonocytic leukemia ( M4 )</keyword>
	<keyword>childhood acute monocytic leukemia ( M5b )</keyword>
	<keyword>childhood acute monoblastic leukemia ( M5a )</keyword>
	<keyword>secondary acute myeloid leukemia</keyword>
	<keyword>untreated childhood acute lymphoblastic leukemia</keyword>
	<keyword>untreated childhood acute myeloid leukemia myeloid malignancy</keyword>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
	<keyword>recurrent childhood acute myeloid leukemia</keyword>
</DOC>